NA89
NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED
12/17/2021
Back to search
Official data from USPTO
TARSA THERAPEUTICS
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: United States
Quick snapshot
TARSA THERAPEUTICS
ST13
US500000077980945Class
42
Filing
77980945
Registration
3912357
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
39
Latest update
12/17/2021
Trademark type
Word
Nice classes
42
Filing date
02/24/2010
Registration date
01/25/2011
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
12/17/2021
Last transaction
12/17/2021
Responsible office
United States Patent and Trademark Office
Status code
800
Official register
Principal Register
Filing basis
Intent to use
First use anywhere
07/22/2010
First use in commerce
07/22/2010
Drawing code
4
Owner type
03
Owner location
Philadelphia, PA
Examiner
CHOSID, ROBIN
Law office
L20
Current location
GENERIC WEB UPDATE
Holders and representatives
Holders
Tarsa Therapeutics,Inc.
Representatives
Susan Neuberger Weller MINTZ, LEVIN, COHN, FERRIS, GLOVSKY AND POPEO, P.C
Technical classification
Nice Classes
Class 42
Vienna Codes
No Vienna codes available.
Goods and services
Class 42
Research and drug development services in the field of pharmaceuticals and biopharmaceuticals; medical and scientific researchconducting clinical trials in the field of pharmaceuticals and biopharmaceuticals
Publications
History of USPTO decisions and trademark events.
39 publications found
RNL1
REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS)
12/17/2021
89AG
REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED
12/17/2021
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
12/17/2021
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
07/20/2021
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
07/20/2021
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
07/20/2021
E89R
TEAS SECTION 8 & 9 RECEIVED
07/15/2021
REM2
COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
01/25/2020
NA85
NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
03/14/2017
C15A
REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
03/14/2017
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
03/14/2017
E815
TEAS SECTION 8 & 15 RECEIVED
01/11/2017
R.PR
REGISTERED-PRINCIPAL REGISTER
01/25/2011
SUNA
NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
12/23/2010
REGV
LAW OFFICE REGISTRATION REVIEW COMPLETED
12/22/2010
CNPR
ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
12/22/2010
SUPC
STATEMENT OF USE PROCESSING COMPLETE
12/02/2010
DPCC
DIVISIONAL PROCESSING COMPLETE
12/02/2010
AITU
CASE ASSIGNED TO INTENT TO USE PARALEGAL
12/01/2010
IUAF
USE AMENDMENT FILED
11/12/2010
DRRR
DIVISIONAL REQUEST RECEIVED
11/12/2010
EISU
TEAS STATEMENT OF USE RECEIVED
11/12/2010
ERTD
TEAS REQUEST TO DIVIDE RECEIVED
11/12/2010
NOAM
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
10/12/2010
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
08/17/2010
PUBO
PUBLISHED FOR OPPOSITION
08/17/2010
PREV
LAW OFFICE PUBLICATION REVIEW COMPLETED
07/14/2010
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
07/13/2010
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
07/10/2010
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
07/10/2010
ALIE
ASSIGNED TO LIE
07/10/2010
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
06/22/2010
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
06/02/2010
GNRT
NON-FINAL ACTION E-MAILED
06/02/2010
CNRT
NON-FINAL ACTION WRITTEN
06/02/2010
DOCK
ASSIGNED TO EXAMINER
05/28/2010
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
03/02/2010
NWAP
NEW APPLICATION ENTERED
02/27/2010
Continuous trademark protection
Get notified about every new filing that threatens TARSA THERAPEUTICS or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.